Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Arsenic methylation and lung and bladder cancer in a case-control study in northern Chile.

Melak D, Ferreccio C, Kalman D, Parra R, Acevedo J, Pérez L, Cortés S, Smith AH, Yuan Y, Liaw J, Steinmaus C.

Toxicol Appl Pharmacol. 2014 Jan 15;274(2):225-31. doi: 10.1016/j.taap.2013.11.014. Epub 2013 Dec 1.

2.

Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina.

Steinmaus C, Yuan Y, Kalman D, Rey OA, Skibola CF, Dauphine D, Basu A, Porter KE, Hubbard A, Bates MN, Smith MT, Smith AH.

Toxicol Appl Pharmacol. 2010 Sep 1;247(2):138-45. doi: 10.1016/j.taap.2010.06.006. Epub 2010 Jun 17.

3.

Elevated lung cancer in younger adults and low concentrations of arsenic in water.

Steinmaus C, Ferreccio C, Yuan Y, Acevedo J, González F, Perez L, Cortés S, Balmes JR, Liaw J, Smith AH.

Am J Epidemiol. 2014 Dec 1;180(11):1082-7. doi: 10.1093/aje/kwu238. Epub 2014 Nov 4.

4.

Arsenic, tobacco smoke, and occupation: associations of multiple agents with lung and bladder cancer.

Ferreccio C, Yuan Y, Calle J, Benítez H, Parra RL, Acevedo J, Smith AH, Liaw J, Steinmaus C.

Epidemiology. 2013 Nov;24(6):898-905. doi: 10.1097/EDE.0b013e31829e3e03.

5.

Arsenic methylation capacity is associated with breast cancer in northern Mexico.

López-Carrillo L, Hernández-Ramírez RU, Gandolfi AJ, Ornelas-Aguirre JM, Torres-Sánchez L, Cebrian ME.

Toxicol Appl Pharmacol. 2014 Oct 1;280(1):53-9. doi: 10.1016/j.taap.2014.07.013. Epub 2014 Jul 22.

PMID:
25062773
6.

Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water.

Smith AH, Goycolea M, Haque R, Biggs ML.

Am J Epidemiol. 1998 Apr 1;147(7):660-9.

PMID:
9554605
7.

Drinking water arsenic in northern chile: high cancer risks 40 years after exposure cessation.

Steinmaus CM, Ferreccio C, Romo JA, Yuan Y, Cortes S, Marshall G, Moore LE, Balmes JR, Liaw J, Golden T, Smith AH.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):623-30. doi: 10.1158/1055-9965.EPI-12-1190. Epub 2013 Jan 25.

8.

Methylation study of a population environmentally exposed to arsenic in drinking water.

Hopenhayn-Rich C, Biggs ML, Smith AH, Kalman DA, Moore LE.

Environ Health Perspect. 1996 Jun;104(6):620-8.

9.

Increased lung and bladder cancer incidence in adults after in utero and early-life arsenic exposure.

Steinmaus C, Ferreccio C, Acevedo J, Yuan Y, Liaw J, Durán V, Cuevas S, García J, Meza R, Valdés R, Valdés G, Benítez H, VanderLinde V, Villagra V, Cantor KP, Moore LE, Perez SG, Steinmaus S, Smith AH.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1529-38. doi: 10.1158/1055-9965.EPI-14-0059. Epub 2014 May 23.

10.

Arsenic methylation and bladder cancer risk in Taiwan.

Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, Lee MS, Christiani DC.

Cancer Causes Control. 2003 May;14(4):303-10.

PMID:
12846360
11.

Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States.

Steinmaus C, Bates MN, Yuan Y, Kalman D, Atallah R, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Hoang BK, Smith AH.

J Occup Environ Med. 2006 May;48(5):478-88.

PMID:
16688004
12.

Urinary arsenic speciation profile in ethnic group of the Atacama desert (Chile) exposed to variable arsenic levels in drinking water.

Yáñez J, Mansilla HD, Santander IP, Fierro V, Cornejo L, Barnes RM, Amarasiriwardena D.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2015;50(1):1-8. doi: 10.1080/10934529.2015.964594.

PMID:
25438126
13.

Profile of urinary arsenic metabolites during pregnancy.

Hopenhayn C, Huang B, Christian J, Peralta C, Ferreccio C, Atallah R, Kalman D.

Environ Health Perspect. 2003 Dec;111(16):1888-91.

14.

Case-control study of arsenic in drinking water and kidney cancer in uniquely exposed Northern Chile.

Ferreccio C, Smith AH, Durán V, Barlaro T, Benítez H, Valdés R, Aguirre JJ, Moore LE, Acevedo J, Vásquez MI, Pérez L, Yuan Y, Liaw J, Cantor KP, Steinmaus C.

Am J Epidemiol. 2013 Sep 1;178(5):813-8. doi: 10.1093/aje/kwt059. Epub 2013 Jun 13.

15.

Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.

Pu YS, Yang SM, Huang YK, Chung CJ, Huang SK, Chiu AW, Yang MH, Chen CJ, Hsueh YM.

Toxicol Appl Pharmacol. 2007 Jan 15;218(2):99-106. Epub 2006 Nov 10.

PMID:
17196235
16.

Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water.

Hopenhayn-Rich C, Biggs ML, Kalman DA, Moore LE, Smith AH.

Environ Health Perspect. 1996 Nov;104(11):1200-7.

17.

Urinary arsenic species, toenail arsenic, and arsenic intake estimates in a Michigan population with low levels of arsenic in drinking water.

Rivera-Núñez Z, Meliker JR, Meeker JD, Slotnick MJ, Nriagu JO.

J Expo Sci Environ Epidemiol. 2012 Mar-Apr;22(2):182-90. doi: 10.1038/jes.2011.27. Epub 2011 Aug 31.

PMID:
21878987
18.

Dietary intake and arsenic methylation in a U.S. population.

Steinmaus C, Carrigan K, Kalman D, Atallah R, Yuan Y, Smith AH.

Environ Health Perspect. 2005 Sep;113(9):1153-9.

19.

Lung cancer and arsenic concentrations in drinking water in Chile.

Ferreccio C, González C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH.

Epidemiology. 2000 Nov;11(6):673-9. Erratum in: Epidemiology 2001 Mar;12(2):283.

PMID:
11055628
20.

Case-control study of arsenic in drinking water and lung cancer in California and Nevada.

Dauphiné DC, Smith AH, Yuan Y, Balmes JR, Bates MN, Steinmaus C.

Int J Environ Res Public Health. 2013 Aug 2;10(8):3310-24. doi: 10.3390/ijerph10083310.

Supplemental Content

Support Center